Biomx Inc Stock In The News

PHGE Stock  USD 0.43  0.0008  0.19%   
Our overall analysis of Biomx's news coverage and content from conventional and social sources shows investors' bearish mood towards Biomx Inc. The specific impact of Biomx news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Biomx's overall financial health and prospects. It also depends on the type and quality of a news publisher. Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Biomx headlines in addition to utilizing other, more conventional financial analysis modules. Check out Biomx Backtesting and Biomx Hype Analysis.

Biomx Today Top News and Investor Outlook

Investing News at Macroaxis
BiomX begins phase 2b trial for phage therapy targeting CF infections
https://www.investing.com/news/company-news/biomx-begins-phase-2b-trial-for-phage-therapy-targeting-cf-infections-93CH-4133941
 Neutral
Macroaxis News: globenewswire.com
BiomX Announces Positive Topline Results...
https://www.globenewswire.com/news-release/2023/11/29/2787575/0/en/BiomX-Announces-Positive-Topline-Results-from-Part-2-of-the-Phase-1b-2a-Trial-Evaluating-BX004-for-Treatment-of-Chronic-Pulmonary-Infections-in-Patients-with-Cystic-Fibrosis.html
 Neutral
Macroaxis News: globenewswire.com
BiomX Reports Third Quarter 2023 Financial Results and Provides Business Update
https://www.globenewswire.com/news-release/2023/11/14/2779861/0/en/BiomX-Reports-Third-Quarter-2023-Financial-Results-and-Provides-Business-Update.html
 Neutral
Macroaxis News: globenewswire.com
BiomX to Present Data from Ongoing Phase...
https://www.globenewswire.com/news-release/2023/10/27/2768361/0/en/BiomX-to-Present-Data-from-Ongoing-Phase-1b-2a-Study-Evaluating-BX004-for-the-Treatment-of-Chronic-Pseudomonas-aeruginosa-Pulmonary-Infections-in-Patients-with-Cystic-Fibrosis-at-t.html
 Neutral
Macroaxis News: globenewswire.com
BiomX Announces the Appointment of Edward L. Williams to its Board of Directors
https://www.globenewswire.com/news-release/2023/10/18/2762270/0/en/BiomX-Announces-the-Appointment-of-Edward-L-Williams-to-its-Board-of-Directors.html
 Bullish
Macroaxis News: globenewswire.com
BiomX Announces Completion of Patient Do...
https://www.globenewswire.com/news-release/2023/10/04/2754399/0/en/BiomX-Announces-Completion-of-Patient-Dosing-in-Part-2-of-the-Phase-1b-2a-Study-Evaluating-BX004-for-Treatment-of-Chronic-Pulmonary-Infections-in-Patients-with-Cystic-Fibrosis.html
 Neutral
Macroaxis News: globenewswire.com
BiomX to Present Data from Ongoing Phase...
https://www.globenewswire.com/news-release/2023/09/07/2739444/0/en/BiomX-to-Present-Data-from-Ongoing-Phase-1b-2a-Study-Evaluating-BX004-for-the-Treatment-of-Chronic-Pseudomonas-aeruginosa-Pulmonary-Infections-in-Patients-with-Cystic-Fibrosis-at-t.html
 Neutral
Macroaxis News: globenewswire.com
BiomX to Present at H.C. Wainwright 25th Annual Global Investment Conference
https://www.globenewswire.com/news-release/2023/09/06/2738852/0/en/BiomX-to-Present-at-H-C-Wainwright-25th-Annual-Global-Investment-Conference.html
 Neutral
Macroaxis News: globenewswire.com
BiomX Reports Second Quarter 2023 Financial Results and Provides Business Update
https://www.globenewswire.com/news-release/2023/08/09/2721423/0/en/BiomX-Reports-Second-Quarter-2023-Financial-Results-and-Provides-Business-Update.html
 Neutral
Macroaxis News: globenewswire.com
BiomX to Host Second Quarter 2023 Financial Results Conference Call and Webcast on August 9th, 2023
https://www.globenewswire.com/news-release/2023/08/02/2717433/0/en/BiomX-to-Host-Second-Quarter-2023-Financial-Results-Conference-Call-and-Webcast-on-August-9th-2023.html
 Bullish

Biomx Inc Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Biomx and other traded companies coverage with news coverage. We help investors stay connected with Biomx headlines for the 29th of July to make an informed investment decision based on correlating the impacts of news items on Biomx Stock performance. Please note that trading solely based on the Biomx Inc hype is not for everyone as timely availability and quick action are needed to avoid losses.
Biomx's linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Biomx Inc investors visualize upcoming and past events in order to time the market based on Biomx Inc noise-free hype analysis.

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Biomx in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Biomx's short interest history, or implied volatility extrapolated from Biomx options trading.
When determining whether Biomx Inc is a strong investment it is important to analyze Biomx's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Biomx's future performance. For an informed investment choice regarding Biomx Stock, refer to the following important reports:
Check out Biomx Backtesting and Biomx Hype Analysis.
You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biomx. If investors know Biomx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biomx listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
23.03
Return On Assets
(0.37)
Return On Equity
(0.34)
The market value of Biomx Inc is measured differently than its book value, which is the value of Biomx that is recorded on the company's balance sheet. Investors also form their own opinion of Biomx's value that differs from its market value or its book value, called intrinsic value, which is Biomx's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biomx's market value can be influenced by many factors that don't directly affect Biomx's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biomx's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biomx is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biomx's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.